Ryunosuke Ohkawa Selected Research

Lipids

9/2023	Characterization of novel truncated apolipoprotein A-I in human high-density lipoprotein generated by sequential treatment with myeloperoxidase and chymase.
10/2020	Cholesterol Efflux-Independent Modification of Lipid Rafts by AIBP (Apolipoprotein A-I Binding Protein).
1/2019	Exosomes containing HIV protein Nef reorganize lipid rafts potentiating inflammatory response in bystander cells.
1/2018	[Successful readministration of L-asparaginase after development of severe hypertriglyceridemia in a young adult with T-cell acute lymphoblastic leukemia].
1/2017	Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.
1/2015	LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate.
9/2013	[Sphingolipids, possible biomarkers for atherosclerotic disorders].
8/2013	Necessity of lysophosphatidic acid receptor 1 for development of arthritis.
7/2013	Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome.
5/2010	Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryunosuke Ohkawa Research Topics

Disease

10	Atherosclerosis 01/2023 - 11/2010
9	Inflammation (Inflammations) 09/2023 - 10/2008
8	Acute Coronary Syndrome 01/2018 - 12/2011
7	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 11/2012
7	Neoplasms (Cancer) 11/2016 - 09/2006
5	Liver Cirrhosis (Hepatic Cirrhosis) 07/2018 - 09/2007
4	Atherosclerotic Plaque (Atheroma) 09/2023 - 11/2010
4	Hepatocellular Carcinoma (Hepatoma) 08/2014 - 08/2012
3	Diabetic Nephropathies (Diabetic Nephropathy) 02/2021 - 01/2010
3	Melanoma (Melanoma, Malignant) 02/2021 - 07/2007
3	Fibrosis (Cirrhosis) 07/2018 - 09/2007
3	Chronic Hepatitis C 08/2014 - 07/2007
2	Diabetes Mellitus 07/2021 - 07/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 06/2017 - 11/2012
2	Lymphoma (Lymphomas) 11/2016 - 10/2008
2	Stable Angina 02/2015 - 11/2012
2	Obesity 12/2014 - 12/2013
2	Liver Diseases (Liver Disease) 06/2011 - 11/2009
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2008 - 01/2007
1	Sepsis (Septicemia) 12/2023
1	COVID-19 12/2023
1	Glaucoma 02/2021
1	Lupus Nephritis 02/2021
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 11/2019
1	Chronic Hepatitis B 07/2018
1	Non-alcoholic Fatty Liver Disease 07/2018
1	Hepatitis C 07/2018
1	Hepatitis B 07/2018
1	Chronic Renal Insufficiency 07/2018
1	Rheumatoid Arthritis 07/2018
1	Hypertriglyceridemia 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Leukemia 01/2018
1	Pancreatitis 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018
1	Paraproteinemias (Monoclonal Gammopathy) 11/2016
1	Proteinuria 01/2016
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Infections 01/2016
1	Phenylketonurias (Phenylketonuria) 01/2014
1	Alkaptonuria 01/2014

Drug/Important Bio-Agent (IBA)

14	LipidsIBA 09/2023 - 09/2006
11	HDL LipoproteinsIBA 09/2023 - 01/2015
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2010
10	lysophosphatidic acidIBA 01/2018 - 09/2006
8	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2015 - 12/2008
7	EnzymesIBA 09/2023 - 07/2007
7	CholesterolIBA 01/2023 - 11/2010
7	AntigensIBA 07/2018 - 02/2008
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2023 - 01/2016
5	Messenger RNA (mRNA)IBA 06/2014 - 09/2007
4	Choline (Choline Chloride)IBA 01/2018 - 07/2007
4	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2018 - 07/2007
4	alkylglycerophosphoethanolamine phosphodiesteraseIBA 01/2018 - 11/2007
3	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2016
3	HomocysteineIBA 01/2022 - 01/2016
3	LysophospholipidsIBA 02/2021 - 02/2015
3	Lipoproteins (Lipoprotein)IBA 01/2021 - 01/2016
3	Hyaluronic Acid (Hyaluronan)IBA 07/2018 - 05/2010
3	SphingosineIBA 06/2014 - 01/2007
2	HDL CholesterolIBA 09/2023 - 01/2021
2	Peroxidase (Myeloperoxidase)IBA 09/2023 - 01/2022
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021 - 01/2016
2	AntioxidantsIBA 01/2016 - 01/2015
2	Mitochondrial Form Creatine KinaseIBA 08/2014 - 05/2014
2	Phosphates (Orthophosphate)IBA 06/2014 - 01/2007
2	Conditioned Culture MediaIBA 12/2013 - 09/2012
2	SphingomyelinsIBA 09/2013 - 11/2012
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 11/2012 - 12/2011
2	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 09/2012 - 07/2007
2	oxidized low density lipoproteinIBA 01/2012 - 11/2010
2	Sphingosine-1-Phosphate ReceptorsIBA 11/2010 - 01/2007
2	Carbon Tetrachloride (Tetrachloromethane)IBA 05/2010 - 09/2007
1	ThrombomodulinIBA 12/2023
1	Chymases (Chymase)IBA 09/2023
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2022
1	Phospholipases A1 (Phospholipase A1)IBA 02/2021
1	PhosphatidylserinesIBA 02/2021
1	polyacrylamideIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 10/2020
1	Collagen Type IV (Type IV Collagen)IBA 07/2018
1	Asparaginase (Elspar)FDA Link 01/2018
1	lysophosphatidylserineIBA 01/2017
1	Immunoglobulin M (IgM)IBA 11/2016
1	ParaproteinsIBA 11/2016
1	HaptoglobinsIBA 11/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	quinone (benzoquinone)IBA 01/2014
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2014
1	Homogentisic AcidIBA 01/2014
1	AcidsIBA 01/2014
1	SolutionsIBA 01/2014
1	AlkaliesIBA 01/2014
1	Homogentisate 1,2-Dioxygenase (Homogentisate 1,2 Dioxygenase)IBA 01/2014

Therapy/Procedure

3	Therapeutics 01/2018 - 01/2007
1	Orthopedic Procedures 01/2021
1	Remission Induction 01/2018
1	Percutaneous Coronary Intervention 06/2017
1	Blood Transfusion (Blood Transfusions) 12/2013